Funds advised by BC Partners have acquired the shares in the Aenova Group from private equity firm Bridgepoint.
Headquartered in Pähl, near Munich, the Aenova Group is a service provider in the pharmaceuticals and healthcare industry.
The purchase price was not disclosed. The acquisition is currently awaiting clearance from the competition authorities.
A team led by lead partner Udo Simmat advised BC Partners on all aspects of the international transaction from the start. With CMS Hasche Sigle in the lead role, the transaction was completed within a very short period in conjunction with CMS member firms in Switzerland, Romania and Luxembourg, together with White & Case in France and Alston Bird in the US.
Private equity firm BC Partners has been a client of CMS Hasche Sigle for many years.
The Aenova Group develops and produces soft capsules, tablets and packaging solutions at eight sites in Europe and the US, employing some 1,600 people. The group was created in 2008 via the merger of Dragenopharm Apotheker Püschl and SWISS CAPS.
The finance agreements were negotiated in conjunction with Freshfields Bruckhaus Deringer.
